Interactions of the potent synthetic AT1 antagonist analog BV6 with membrane bilayers and mesoporous silicate matrices-Reference-Cited by-同舟云学术

Interactions of the potent synthetic AT1 antagonist analog BV6 with membrane bilayers and mesoporous silicate matrices

Published:2013-08 Issue:8 Volume:1828 Page:1846-1855
ISSN:0005-2736
Container-title:Biochimica et Biophysica Acta (BBA) - Biomembranes
language:en
Short-container-title:Biochimica et Biophysica Acta (BBA) - Biomembranes

Author:

Agelis G.,Resvani A.,Ntountaniotis D.,Chatzigeorgiou P.,Koukoulitsa C.,Androutsou M.E.,Plotas P.,Matsoukas J.,Mavromoustakos T.,Čendak T.,Godec T. Ukmar,Mali G.

Funder

Slovenian Research Agency

Publisher

Elsevier BV

Subject

Cell Biology,Biochemistry,Biophysics

Reference38 articles.

1. Comparative assessment of angiotensin receptor blockers in different clinical settings;Verdecchia;Vasc. Health Risk Manag.,2009

2. Choosing among renin–angiotensin system blockers for the management of hypertension from pharmacology to clinical efficacy;Neutel;Curr. Med. Res. Opin.,2010

3. Angiotensin II receptor type 1 (AT1) selective nonpeptidic antagonists—a perspective;Naik;Bioorg. Med. Chem.,2010

4. Effects of the angiotensin receptor blocker azilsartan medoxomil versus olmesartan and valsartan on ambulatory and clinic blood pressure in patients with stages 1 and 2 hypertension;White;Hypertension,2011

5. International Union of Pharmacology. XXIII. The angiotensin II receptors;De Gasparo;Pharmacol. Rev.,2000

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel benzimidazole angiotensin receptor blockers with anti-SARS-CoV-2 activity equipotent to that of nirmatrelvir: computational and enzymatic studies;Expert Opinion on Therapeutic Targets;2024-05-03

2. Understanding the Driving Forces That Trigger Mutations in SARS-CoV-2: Mutational Energetics and the Role of Arginine Blockers in COVID-19 Therapy;Viruses;2022-05-11

3. Discovery of a new generation of angiotensin receptor blocking drugs: Receptor mechanisms and in silico binding to enzymes relevant to SARS-CoV-2;Computational and Structural Biotechnology Journal;2022

4. From Angiotensin II to Cyclic Peptides and Angiotensin Receptor Blockers (ARBs): Perspectives of ARBs in COVID-19 Therapy;Molecules;2021-01-25

5. Transdermal Delivery of AT1 Receptor Antagonists Reduce Blood Pressure and Reveal a Vasodilatory Effect on Kidney Blood Vessels;Current Molecular Pharmacology;2018-07-02